Avignon, 25 July 2014 - Naturex, the global leader in specialty plant-based natural ingredients, announces its 2014 first-half consolidated revenue:
|
K€ IFRS unaudited data |
H1 FY 2014 | H1 FY 2013 | Change % | Change % at constant exchange rates |
| Reported Revenue | 158 341 | 165 754 | -4,5% | -1,8% |
| of which Svetol sales (included in the N&H activity) | 1 850 | 7 287 | ||
| of which krill extraction (included in Toll Manufacturing) | 5 032 | 6 830 | ||
| Restated revenue* Excl. Svetol and krill extraction sales | 151 458 | 151 637 | -0,1% | +2,8% |
* 2013 was marked by strong sales from Svetol® in the 1st half in response to extensive media coverage and Toll Manufacturing sales including krill extraction sales for AKER BioMarine that were very robust in the 1st quarter. The major portion of krill extraction activity for AKER BioMarine, recognised under Toll Manufacturing will be transferred outside the reporting scope for revenue starting in the 2014 second half, in light of the commencement of operations of the joint venture created with AKER BioMarine.
In line with trends registered at the start of the year and as expected, 2014 first-half sales came to €158.3 million with a marginal decrease reflecting mainly:
Restated to adjust for Svetol® and krill toll manufacturing sales, first-half revenue was up 2.8% at constant exchange rates.
Strong contribution from Food & Beverage
|
K€ IFRS Restated sales |
H1 FY 2014 | H1 FY 2013 |
Revenue Mix % |
Change % |
Change % constant exchange rates |
| Food & Beverage | 98 672 | 94 149 | 65,1% | +4,8% | +7,8% |
| Nutrition & Health | 47 216 | 51 777 | 31,2% | -8,8% | -6,0% |
| Personal Care | 3 174 | 3 025 | 2,1% | +4,9% | +6,5% |
| Toll-Manufacturing | 2 397 | 2 686 | 1,6% | -10,8% | -7,6% |
The integration of sales from Chile Botanics (January 2014) and Vegetables Juices Inc. (June 2014) has also contributed to additional growth.
Positive momentum in all geographic regions
|
K€ IFRS Restated sales2 |
H1 FY 2014 | H1 FY 2013 |
Revenue Mix % |
Change % |
Change % at constant exchange rates |
| Europe / Africa | 70 572 | 71 518 | 46,6% | -1,3% | -1,6% |
| Americas | 62 013 | 61 217 | 40,9% | +1,3% | +6,2% |
| Asia / Pacific | 18 873 | 18 902 | 12,5% | -0,2% | +8,3% |
Over the first half, with growth at constant exchange rates of 7.7%, all emerging countries accounted for 18% of Group sales, up from 16.4% from last year's same period.
“Sales in the 2014 first half confirmed, in line with expectations, trends reported at the start of the year in terms of growth profile in a foreign exchange environment that remains challenging. Our new organisation and the clarification of our offering have started to produce results, and in particular, provide real momentum to the Food & Beverage business, and on that basis, we can look to the second half with confidence", commented Thierry Lambert, Naturex's Chairman and Chief Executive Officer. "Several projects in progress are expected to lead to concrete developments in the coming months, and with the synergies to be obtained from the continuing integration of acquisitions, will provide sources of additional growth."
You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com
Financial Schedule
- 2014 first-half results: 29 August 2014
- 2014 third-quarter sales: 4 November 2014
- 2014 third-quarter results: 28 November 2014
- Annual revenue: 3 February 2015
- Annual results: 31 March 2015
Upcoming Events
- SFAF analysts Meeting: 2 September 2014
Appendix: see attachment
Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B
Total number of shares comprising the share capital: 9,182,307
ISIN FR0000054694
NATUREX is a component of the CAC PEA-PME, CAC Small, Gaïa Index.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD).
TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY
About Naturex
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex’s head office is based in Avignon. The company employs more than 1,600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries
Contacts
Thierry Lambert
Chair and Chief Executive Officer
Tel.: +33 (0)4 90 23 96 89
t.lambert@naturex.com
Thierry-Bertrand Lambert
Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
t.b.lambert@naturex.com
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
acbonjour@actus.fr